Care

England aims to reach the WHO elimination target of decreasing HCV incidence among PWID to <2/100pyrs by 2030. A study assessed what testing and treatment strategies will achieve this target and whether they are cost-effective. More

The new prison-based test-and-treat model for HCV infection demonstrates promising feasibility, as indicated by high screening coverage and successful implementation across the HCV care cascade using existing resources. More

Collaborative care models with integrated pharmacy teams enhance HCV treatment initiation at diagnosis for marginalized populations; The NOW trial demonstrated the feasibility of same-day HCV treatment initiation in US. More

Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis. More

A paper presents the development of the METRIC toolkit, aimed at enhancing primary healthcare interventions in the context of hepatitis C control, thus contributing to WHO global strategy to achieve the elimination of the disease by 2030. More

A study examined the long-term cost-effectiveness of routine HCV screening and linkage-to-care for high-risk patients in the US emergency department from the payer’s perspective. More

A study designed a simplified model of HCV care and estimated the cost of screening and treatment of hepatitis C infection at a tertiary hospital in Zimbabwe. More

History has been made in Glasgow, Scotland, with the opening of The Thistle, the United Kingdom’s first Safer Drug Consumption Facility, on 13 January 2025. More

A Montreal study assigned patient navigators to 10 men released from prison with hepatitis C; Navigators’ knowledge and attitudes were more important to participants than lived experience. More

MSF: "We learned that any serious effort to combat this disease has to tackle not just the medical aspects, but also the social conditions that allow it to spread." More